News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
News FDA removes leash from Verzenio in early breast cancer Drug can now be used as adjuvant therapy without Ki-67 testing, taking a brake off prescribing.
News Sanofi gets FDA nod for long-acting haemophilia A drug Once-weekly Altuviiio could be potential $2 billion-plus blockbuster, according to analysts.
News CSL’s Hemgenix is first haemophilia B gene therapy in EU Firm will work with payers to try to secure access for as many patients across EU as possible.
News Apellis breaks new ground in geographic atrophy Syfovre is the first FDA-approved drug for GA, which damages the sight of 5m people worldwide.
News Gilead buoyed by Trodelvy OK in new breast cancer use The reversal of fortunes for Gilead Sciences' Trodelvy in an advanced form of breast cancer is complete, with an FDA approval unlocking what could be a sizeable new market
Oncology Getting predictive technologies to patients, with Concr Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
